Mosanna Therapeutics

Bioscience & Disease Healthcare Systems Personal Health

Bioscience & Disease Healthcare Systems +1

Website Not specified , Not specified , Not specified

About Mosanna Therapeutics

Mosanna Therapeutics is a clinical-stage biotech company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) through an easy-to-use nighttime nasal spray that engages the body's natural control of the upper airway.

Business Information

Target Customers

patients with obstructive sleep apnea healthcare providers pharmaceutical distributors

Industry Categories

Bioscience & Disease Healthcare Systems Personal Health

Business Model

Revenue Model Pharmaceutical sales

Pricing Strategy Not specified

Sales Channels direct sales to healthcare providers, partnerships with pharmaceutical distributors

Funding Timeline

Round	Date	Amount	Investors
Series A	Jun 12, 2025	$70.1M	Unknown
Series A	Jun 10, 2025	$80.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

Raising.fi @raisingfi

Jun 10, 2025

New Raise 🏛️ Company: Mosanna Therapeutics 🔗 Website: https://t.co/BheUc5cKN1 📊 Amount: $80 Million 🔄 Round: Series A 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

IVCA @IndianVCA

Jun 12, 2025

Biotech startup Mosanna secures € 70.1 million in series A round https://t.co/FzuQDdhX2d https://t.co/7ZIqpieIXm

View on Twitter

Similar Startups

MdBreathe

83% match

MdBreathe is a medical technology startup focused on developing innovative solutions for respiratory...

AusperBio

83% match

A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.

MindSpire

83% match

MindSpire is a neurotechnology startup dedicated to helping individuals regulate stress and unlock p...

Avammune Therapeutics

83% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...